Paper · 70221

Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction.

Haseltine WA and 6 others. Biochemistry, 1977. Cited by 49 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction. Papers, record 70221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/70221

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction.; PubMed
Journal: Biochemistry; PubMed
Year: 1977; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/70221/; PubMed
DOI: https://doi.org/10.1021/bi00635a019; PubMed
The journal: https://conductscience.org/library/journal-index/0370623; PubMed
Citations, by iCite: 49; iCite
Relative citation ratio, by iCite: 0.98; iCite
Revised in PubMed: 2019-06-12; PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Haseltine WA	W A
2	Panet A	A
3	Smoler D	D
4	Baltimore D	D
5	Peters G	G
6	Harada F	F
7	Dahlberg JE	J E

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Avian Leukosis Virus	Major topic
Avian Myeloblastosis Virus	Major topic
RNA, Transfer	Major topic
RNA-Directed DNA Polymerase	Major topic
Antigen-Antibody Reactions
Ethylmaleimide
Kinetics
Molecular Weight
Moloney murine leukemia virus
Protein Binding
Structure-Activity Relationship
Transcription, Genetic
Tryptophan

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMID	Title	Journal	Year	In Papers	Source
38,684,316	Human T-cell leukemia virus type 1 uses a specific tRNAPro isodecoder to prime reverse transcription.	RNA	2024	https://conductscience.org/library/papers/38684316	PubMed
10,637,332	Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.	Nucleic Acids Res	2000	https://conductscience.org/library/papers/10637332	PubMed
10,364,369	Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.	J Virol	1999	https://conductscience.org/library/papers/10364369	PubMed
9,261,422	Placement of tRNA primer on the primer-binding site requires pol gene expression in avian but not murine retroviruses.	J Virol	1997	https://conductscience.org/library/papers/9261422	PubMed
9,016,594	Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro.	Nucleic Acids Res	1997	https://conductscience.org/library/papers/9016594	PubMed
8,995,641	Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.	J Virol	1997	https://conductscience.org/library/papers/8995641	PubMed
8,464,701	Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site.	Nucleic Acids Res	1993	https://conductscience.org/library/papers/8464701	PubMed
7,707,537	Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).	J Virol	1995	https://conductscience.org/library/papers/7707537	PubMed
7,693,968	Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.	J Virol	1993	https://conductscience.org/library/papers/7693968	PubMed
7,545,245	Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.	J Virol	1995	https://conductscience.org/library/papers/7545245	PubMed

1 to 10 of 20

See all 20 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/70221

GET https://conductscience.org/api/papers/v1/70221/authors

API reference For AI assistants